HomeCLDX • NASDAQ
add
Celldex Therapeutics, Inc.
Previous close
$32.86
Day range
$31.22 - $33.32
Year range
$22.11 - $53.18
Market cap
2.20B USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.50M | 832.09% |
Operating expense | 44.93M | 45.01% |
Net income | -35.84M | -17.51% |
Net profit margin | -1.43K | 87.39% |
Earnings per share | -0.54 | 16.92% |
EBITDA | -45.52M | -40.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 802.32M | 217.50% |
Total assets | 845.59M | 182.51% |
Total liabilities | 31.93M | 46.63% |
Total equity | 813.66M | — |
Shares outstanding | 66.29M | — |
Price to book | 2.68 | — |
Return on assets | -13.51% | — |
Return on capital | -13.98% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -35.84M | -17.51% |
Cash from operations | -29.33M | -7.84% |
Cash from investing | -46.72M | -4,114.00% |
Cash from financing | 3.71M | 2,690.98% |
Net change in cash | -72.34M | -179.31% |
Free cash flow | -17.54M | -11.65% |
About
Founded
1983
Headquarters
Website
Employees
160